Brief: Oncolytics Biotech Posts Q2 Loss Per Share C$0.13
06/08/2021 12:03
Aug 6 (Reuters) - Oncolytics Biotech Inc ONC.TO :
* ONCOLYTICS BIOTECH® REPORTS 2021 SECOND QUARTER
DEVELOPMENT
HIGHLIGHTS AND FINANCIAL RESULTS
* Q2 LOSS PER SHARE C$0.13
* Q2 EARNINGS PER SHARE ESTIMATE C$-0.12 -- REFINITIV IBES
DATA
* AS OF JUNE 30, 2021, REPORTED $50.8 MILLION IN CASH AND
CASH
EQUIVALENTS.
Source text for Eikon: ID:nCNWQlpp4a
Further company coverage: ONC.TO
((reuters.briefs@thomsonreuters.com;))
Recent news on Oncolytics Biotech
See all newsBrief: Oncolytics Biotech Files For Mixed Shelf Offering Of Up To $150 Million
Brief: Oncolytics Biotech® Announces Voluntary Delisting From The Toronto Stock Exchange
Advisory: Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn
Brief: Oncolytics Biotech® Appoints Former Ambrx Executive As Chief Business Officer
Brief: Oncolytics Biotech Appoints Former Ambrx Executive As Chief Business Officer